High Rejection Rate of Proposed Brand Names On EMA Radar
Executive Summary
In March, the number of proposed new drug brand names rejected by the European Medicines Agency exceeded those that were accepted. A dedicated group at the agency is to look into the problem at a meeting with stakeholders on June 1.